Optimizing Omnipod Settings for Improved Glycemic Control
Assessment and Recommendations
- The American Diabetes Association recommends a target blood glucose range of 70-180 mg/dL for most patients with diabetes, and the current average blood glucose of 212 mg/dL is significantly above this target range 3, 4
- The current Omnipod settings, with a basal rate of 0.6 units/hour, insulin sensitivity factor (ISF) of 85, and insulin-to-carbohydrate ratio (ICR) of 15, appear inadequate to maintain glycemic control, as evidenced by the elevated average blood glucose 1
- Increasing the basal insulin rate by 10-20% from 0.6 to 0.66-0.72 units/hour is recommended as the first step to improve glycemic control, according to the American Association of Clinical Endocrinologists 1, 2
Adjustments and Monitoring
- The American College of Endocrinology suggests that basal insulin should be titrated to an acceptable fasting blood glucose level before making other adjustments, and that the insulin sensitivity factor (ISF) can be decreased from 85 to 70-75 if average blood glucose remains elevated after basal adjustment 2, 5
- The Endocrine Society recommends monitoring fasting blood glucose for 2-3 days after adjustment to evaluate effectiveness, and checking blood glucose levels at least 4 times daily during the adjustment period 2, 4
- Pay special attention to fasting morning glucose and 2-hour postprandial values, and evaluate patterns over 3-5 days before making additional adjustments, as recommended by the American Diabetes Association 1, 2
Important Considerations
- The goal of adjusting Omnipod settings is to achieve a target glucose range of 70-180 mg/dL while minimizing hypoglycemia risk, according to the International Diabetes Federation 3, 4
- Basal insulin should be titrated to an acceptable fasting blood glucose level before making other adjustments, and combination therapy or adjusting prandial insulin coverage should be considered for patients with persistent hyperglycemia despite basal adjustments, as recommended by the American Association of Clinical Endocrinologists 5, 1